IP Verse

Production Of Polypeptides - EP2357250B1

PatentPatent Analysis

EP2357250

PFIZER IRELAND PHARMACEUTICALS
Application Number
EP11156236A
Filing Date
Aug 26, 2005
Status
Revoked
Mar 24, 2023
Grant Date
Oct 6, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3269717B9
EP1789571B1

Bibliography

The patent EP2357250B1 was granted to Pfizer Ireland Pharmaceuticals on Oct 6, 2021 following the initial filing on Aug 26, 2005 under the application number EP11156236A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

JAMES POOLEJul 6, 2022ADMISSIBLE
WITHERS & ROGERSJul 5, 2022ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents